Search Results - "DESMYTER, Jan"

Refine Results
  1. 1

    Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds by Pauwels, R, Balzarini, J, Baba, M, Snoeck, R, Schols, D, Herdewijn, P, Desmyter, J, De Clercq, E

    Published in Journal of virological methods (01-08-1988)
    “…A rapid, sensitive and automated assay procedure was developed for the in vitro evaluation of anti-HIV agents. An HTLV-I transformed T4-cell line, MT-4, which…”
    Get more information
    Journal Article
  2. 2

    Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir) by Esté, J A, Cabrera, C, Schols, D, Cherepanov, P, Gutierrez, A, Witvrouw, M, Pannecouque, C, Debyser, Z, Rando, R F, Clotet, B, Desmyter, J, De Clercq, E

    Published in Molecular pharmacology (01-02-1998)
    “…The human immunodeficiency virus (HIV) inhibitor AR177 (T30177, Zintevir) has been identified as a potent inhibitor of HIV integrase in vitro. The compound is…”
    Get more information
    Journal Article
  3. 3

    Different Population Dynamics of Human T Cell Lymphotropic Virus Type II in Intravenous Drug Users Compared with Endemically Infected Tribes by Salemi, Marco, Lewis, Martha, Egan, John Fergal, Hall, William W., Desmyter, Jan, Vandamme, Anne-Mieke

    “…The phylogeny of human T cell lymphotropic virus type II (HTLV-II) was investigated by using strains isolated from Amerindian and Pygmy tribes, in which the…”
    Get full text
    Journal Article
  4. 4

    Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV by WITVROUW, M, PANNECOUQUE, C, VAN LAETHEM, K, DESMYTER, J, DE CLERCQ, E, VANDAMME, A.-M

    Published in AIDS (London) (20-08-1999)
    “…After the initial discovery of 1-(2-hydroxyethoxymethyl)-6-(phenylthio)thymine (HEPT) and tetrahydroimidazo[4,5,1-jk][1,4]benzodiazepin-2(1H)-one and thione…”
    Get full text
    Journal Article
  5. 5
  6. 6

    African Origin of Human T-Lymphotropic Virus Type 2 (HTLV-2) Supported by a Potential New HTLV-2d Subtype in Congolese Bambuti Efe Pygmies by Vandamme, A M, Salemi, M, Van Brussel, M, Liu, H F, Van Laethem, K, Van Ranst, M, Michels, L, Desmyter, J, Goubau, P

    Published in Journal of Virology (01-05-1998)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  7. 7

    Development of resistance of human immunodeficiency virus type 1 to dextran sulfate associated with the emergence of specific mutations in the envelope gp120 glycoprotein by Este, J A, Schols, D, De Vreese, K, Van Laethem, K, Vandamme, A M, Desmyter, J, De Clercq, E

    Published in Molecular pharmacology (01-07-1997)
    “…Polyanionic compounds are known to inhibit the binding of human immunodeficiency virus (HIV) to CD4+ cells and the subsequent fusion step between the virus and…”
    Get more information
    Journal Article
  8. 8

    Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro by Baba, M, Pauwels, R, Herdewijn, P, De Clercq, E, Desmyter, J, Vandeputte, M

    “…2',3'-Dideoxythymidine (ddThd) and its 2',3'-unsaturated derivative 2',3'-dideoxythymidinene (ddeThd) are potent and selective inhibitors of human…”
    Get more information
    Journal Article
  9. 9

    The Jezierski papers: live polio vaccine development in colobus monkey cells but not chimpanzee cells in the Belgian Congo, 1952–1958 by Desmyter, Jan, Teuwen, Dirk E.

    “…A reading of ten relevant papers by Alexandre Jezierski provides evidence for the only attempt in Central Africa to develop a live oral polio vaccine (OPV)…”
    Get full text
    Journal Article
  10. 10

    Postscript relating to new allegations made by Edward Hooper at The Royal Society Discussion Meeting on 11 September 2000 by Plotkin, Stanley A., Teuwen, Dirk E., Prinzie, Abel, Desmyter, Jan

    “… These were proposed as conclusive evidence for the hypothesis that simian immunodeficiency virus–contaminated CHAT polio vaccine caused the HIV–1 group M…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The simian origins of the pathogenic human T-cell lymphotropic virus type I by Vandamme, Anne-Mieke, Salemi, Marco, Desmyter, Jan

    Published in Trends in Microbiology (01-12-1998)
    “…At least four, and possibly six, molecular subtypes of human T-cell lymphotropic virus type I (HTLV-I) exist: one is confined to Melanesia/Australia, one is…”
    Get full text
    Book Review Journal Article
  13. 13

    Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) by Desmyter, J, Melnick, J L, Rawls, W E

    Published in Journal of Virology (01-10-1968)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Two New Human T-Lymphotropic Virus Type I Phylogenetic Subtypes in Seroindeterminates, a Mbuti Pygmy and a Gabonese, Have Closest Relatives among African STLV-I Strains by Salemi, Marco, Van Dooren, Sonia, Audenaert, Elke, Delaporte, Eric, Goubau, Patrick, Desmyter, Jan, Vandamme, Anne-Mieke

    Published in Virology (New York, N.Y.) (05-07-1998)
    “…Six new HTLV-I strains from seroindeterminate individuals were analyzed: four from Gabon, one from a Mbuti Efe pygmy in Congo (formerly Zaire), and one from a…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Multiple dideoxynucleoside analogue-resistant (MddNR) HIV-1 strains isolated from patients from different European countries by SCHMIT, J.-C, VAN LAETHEM, K, LISSEN, E, WITVROUW, M, DESMYTER, J, DE CLERCQ, E, VANDAMME, A.-M, RUIZ, L, HERMANS, P, SPRECHER, S, SÖNNERBORG, A, LEAL, M, HARRER, T, CLOTET, B, ARENDT, V

    Published in AIDS (London) (22-10-1998)
    “…To study the prevalence of multiple dideoxynucleoside (ddN)-resistant (MddNR) HIV-1 in European patients under treatment with multiple ddN analogues, and to…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1 by Schols, D, Pauwels, R, Desmyter, J, De Clercq, E

    Published in Virology (New York, N.Y.) (01-04-1990)
    “…Eighty to 100% of persistently HIV-1-infected HUT-78 cells express the viral glycoprotein gp120 as demonstrated with anti-gp 120 monoclonal antibody (mAb) and…”
    Get more information
    Journal Article
  20. 20

    Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538) by Schmit, J C, Ruiz, L, Clotet, B, Raventos, A, Tor, J, Leonard, J, Desmyter, J, De Clercq, E, Vandamme, A M

    Published in AIDS (London) (01-08-1996)
    “…To define genotypic and phenotypic resistance patterns following prolonged therapy with the protease inhibitor ritonavir (ABT-538). Seven HIV-1-infected…”
    Get more information
    Journal Article